TAM
TFG Asset Management Portfolio holdings
AUM
$689M
1-Year Est. Return
26.29%
1 Year Est. Return
+26.29%
AUM
$689M
AUM Growth
+$134M
(+24%)
Holding
48
Top Buys
| 1 | +$43.2M | |
| 2 | +$3.11M | |
| 3 | +$2.82M | |
| 4 |
ABVX
Abivax
ABVX
|
+$2.55M |
| 5 |
Alkermes
ALKS
|
+$2.22M |
Top Sells
| 1 | +$7.43M | |
| 2 | +$2.48M | |
| 3 | +$2.13M | |
| 4 |
Acadia Pharmaceuticals
ACAD
|
+$1.61M |
| 5 |
Keros Therapeutics
KROS
|
+$1.34M |
Sector Composition
| 1 | Technology | 40.8% |
| 2 | Healthcare | 11.98% |
| 3 | Energy | 6.01% |
| 4 | Materials | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
UiPath
PATH
$7.39B
| $227M | 30.33% |
16,950,000
+3,227,756
|
|
||
|
KGEI
2
Kolibri Global Energy
KGEI
$142M
| $39.2M | 5.24% |
7,070,568
+1,711
|
|
||
3
Lyft
LYFT
$8.57B
| $22M | 2.94% |
1,000,000
|
|
||
4
Sprinklr
CXM
$1.77B
| $17M | 2.27% |
2,200,000
|
|
||
|
AUTL
5
Autolus Therapeutics
AUTL
$359M
| $15.5M | 2.07% |
9,500,000
|
|
||
6
Workiva
WK
$5.19B
| $12.9M | 1.73% |
150,000
|
|
||
7
Celldex Therapeutics
CLDX
$1.73B
| $7.85M | 1.05% |
303,600
-12,550
|
|
||
8
Tarsus Pharmaceuticals
TARS
$3.41B
| $7.43M | 0.99% |
125,000
-125,000
|
|
||
9
Annexon
ANNX
$628M
| $6.44M | 0.86% |
2,112,455
-697,545
|
|
||
10
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$18.1B
| $5.92M | 0.79% |
72,961
+4,301
|
|
||
11
Axsome Therapeutics
AXSM
$7.56B
| $5.64M | 0.75% |
46,456
+4,925
|
|
||
12
Pharvaris
PHVS
$1.75B
| $4.86M | 0.65% |
194,612
+6,512
|
|
||
13
Scholar Rock
SRRK
$4.43B
| $4.39M | 0.59% |
117,882
+14,400
|
|
||
|
TECX
14
Tectonic Therapeutic
TECX
$396M
| $3.82M | 0.51% |
243,728
+14,896
|
|
||
15
Amylyx Pharmaceuticals
AMLX
$1.58B
| $3.51M | 0.47% |
258,242
+39,492
|
|
||
|
MBX
16
MBX Biosciences
MBX
$1.53B
| $3.11M | 0.42% |
+177,840
|
|
||
17
Immunovant
IMVT
$4.16B
| $3.04M | 0.41% |
188,379
+40,562
|
|
||
18
Dyne Therapeutics
DYN
$3.02B
| $2.82M | 0.38% |
223,181
+84,806
|
|
||
19
Arrowhead Research
ARWR
$7.5B
| $2.82M | 0.38% |
+81,841
|
|
||
|
20
Alkermes
ALKS
$4.8B
| $2.69M | 0.36% |
89,612
+73,980
|
|
||
|
ABVX
21
Abivax
ABVX
$9.69B
| $2.55M | 0.34% |
+30,000
|
|
||
22
Snowflake
SNOW
$84.7B
| $2.26M | 0.3% |
10,000
|
|
||
|
23
Acadia Pharmaceuticals
ACAD
$4.2B
| $1.84M | 0.25% |
86,071
-75,325
|
|
||
24
Hudbay
HBM
$6.71B
| $1.78M | 0.24% |
117,500
+10,500
|
|
||
25
Cameco
CCJ
$38.2B
| $1.34M | 0.18% |
16,015
-3,265
|
|